市場調査レポート

商品コード

性感染症 (STD) 治療の世界市場 (2024～2028年)

Global Sexually Transmitted Diseases (STD) Treatment Market 2024-2028

出版日: 2024年10月05日
発行: TechNavio
ページ情報: 英文 145 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 367,475円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 587,960円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

性感染症 (STD) 治療市場 (2024～2028年)

性感染症 (STD) 治療市場は2023年から2028年に143億米ドル分拡大し、予測期間中に4.5%のCAGRで成長すると予測されます。当レポートでは、性感染症 (STD) 治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。この市場は、STDの有病率の増加、STDに対する有利な償還政策治療範囲の存在、および世界各国政府によるイニシアチブの増加によって牽引されています。

市場範囲
基準年	2024年
終了年	2028年
予測期間	2024～2028年
成長モメンタム	加速
前年比 (2024年)	4.3%
CAGR	4.5%
増分額	143億米ドル

当レポートでは、今後数年間の性感染症 (STD) 治療市場の成長を牽引する主な要因の1つとして、STDの迅速診断の進歩を挙げています。また、様々な団体がSTDや迅速パートナー療法（EPT）に対する認識を高めるために関与するようになっていることも、市場の大きな需要につながると思われます。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 (2023～2028年)
欧州：市場規模と予測 (2023～2028年)
アジア：市場規模と予測 (2023～2028年)
世界のその他の地域：市場規模と予測 (2023～2028年)
米国：市場規模と予測 (2023～2028年)
日本：市場規模と予測 (2023～2028年)
中国：市場規模と予測 (2023～2028年)
ドイツ：市場規模と予測 (2023～2028年)
英国：市場規模と予測 (2023～2028年)
地域別の市場機会

第9章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第10章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第11章競合分析

企業プロファイル
企業の市場ポジショニング
AbbVie Inc.
Aurobindo Pharma Ltd.
Bristol Myers Squibb Co.
Boehringer Ingelheim International GmbH
Dynavax Technologies Corp.
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline Plc
Johnson and Johnson Services Inc.
Merck and Co. Inc.

第12章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Sexually Transmitted Diseases (STD) Treatment Market 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Viral infections - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Viral infections - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Viral infections - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Viral infections - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Bacterial infections - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Bacterial infections - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Bacterial infections - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Bacterial infections - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits51: Chart on Geographic comparison
Exhibits52: Data Table on Geographic comparison
Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits89: Market opportunity By Geographical Landscape ($ billion)
Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2023 and 2028
Exhibits92: Overview on criticality of inputs and factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Companies covered
Exhibits96: Matrix on companies position and classification
Exhibits97: AbbVie Inc. - Overview
Exhibits98: AbbVie Inc. - Product / Service
Exhibits99: AbbVie Inc. - Key news
Exhibits100: AbbVie Inc. - Key offerings
Exhibits101: Aurobindo Pharma Ltd. - Overview
Exhibits102: Aurobindo Pharma Ltd. - Product / Service
Exhibits103: Aurobindo Pharma Ltd. - Key offerings
Exhibits104: Bristol Myers Squibb Co. - Overview
Exhibits105: Bristol Myers Squibb Co. - Product / Service
Exhibits106: Bristol Myers Squibb Co. - Key news
Exhibits107: Bristol Myers Squibb Co. - Key offerings
Exhibits108: Boehringer Ingelheim International GmbH - Overview
Exhibits109: Boehringer Ingelheim International GmbH - Product / Service
Exhibits110: Boehringer Ingelheim International GmbH - Key news
Exhibits111: Boehringer Ingelheim International GmbH - Key offerings
Exhibits112: Dynavax Technologies Corp. - Overview
Exhibits113: Dynavax Technologies Corp. - Product / Service
Exhibits114: Dynavax Technologies Corp. - Key offerings
Exhibits115: F. Hoffmann La Roche Ltd. - Overview
Exhibits116: F. Hoffmann La Roche Ltd. - Business segments
Exhibits117: F. Hoffmann La Roche Ltd. - Key news
Exhibits118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits119: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits120: Gilead Sciences Inc. - Overview
Exhibits121: Gilead Sciences Inc. - Product / Service
Exhibits122: Gilead Sciences Inc. - Key news
Exhibits123: Gilead Sciences Inc. - Key offerings
Exhibits124: GlaxoSmithKline Plc - Overview
Exhibits125: GlaxoSmithKline Plc - Business segments
Exhibits126: GlaxoSmithKline Plc - Key news
Exhibits127: GlaxoSmithKline Plc - Key offerings
Exhibits128: GlaxoSmithKline Plc - Segment focus
Exhibits129: Johnson and Johnson Services Inc. - Overview
Exhibits130: Johnson and Johnson Services Inc. - Business segments
Exhibits131: Johnson and Johnson Services Inc. - Key news
Exhibits132: Johnson and Johnson Services Inc. - Key offerings
Exhibits133: Johnson and Johnson Services Inc. - Segment focus
Exhibits134: Merck and Co. Inc. - Overview
Exhibits135: Merck and Co. Inc. - Business segments
Exhibits136: Merck and Co. Inc. - Key news
Exhibits137: Merck and Co. Inc. - Key offerings
Exhibits138: Merck and Co. Inc. - Segment focus
Exhibits139: Inclusions checklist
Exhibits140: Exclusions checklist
Exhibits141: Currency conversion rates for US$
Exhibits142: Research methodology
Exhibits143: Information sources
Exhibits144: Data validation
Exhibits145: Validation techniques employed for market sizing
Exhibits146: Data synthesis
Exhibits147: 360 degree market analysis
Exhibits148: List of abbreviations

Product Code: IRTNTR74264

Sexually Transmitted Diseases (Std) Treatment Market 2024-2028

The sexually transmitted diseases (Std) treatment market is forecasted to grow by USD 14.3 bn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the sexually transmitted diseases (Std) treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of stds, presence of favorable reimbursement policies treatment coverage for stds, and increased initiatives by governments worldwide.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	4.3%
CAGR	4.5%
Incremental Value	$14.3 bn

Technavio's sexually transmitted diseases (Std) treatment market is segmented as below:

By Type

Viral infections
Bacterial infections
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advances in rapid diagnosis of stds as one of the prime reasons driving the sexually transmitted diseases (Std) treatment market growth during the next few years. Also, increasing involvement of various organizations to create awareness about stds and expedited partner therapy (EPT) will lead to sizable demand in the market.

The report on the sexually transmitted diseases (Std) treatment market covers the following areas:

Sexually Transmitted Diseases (Std) Treatment Market sizing
Sexually Transmitted Diseases (Std) Treatment Market forecast
Sexually Transmitted Diseases (Std) Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted diseases (Std) treatment market vendors that include AbbVie Inc., Affymetrix, Aurobindo Pharma Ltd., Becton Dickinson and Co., Bristol Myers Squibb Co., Boehringer Ingelheim International GmbH, Cepheid Inc., DiaSorin SpA, Dynavax Technologies Corp., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Lupin Ltd., Merck and Co. Inc., and Pfizer Inc.. Also, the sexually transmitted diseases (Std) treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Sexually Transmitted Diseases (STD) Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Sexually Transmitted Diseases (STD) Treatment Market 2018 - 2022 ($ billion)
4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
6.3 Viral infections - Market size and forecast 2023-2028
- Chart on Viral infections - Market size and forecast 2023-2028 ($ billion)
- Data Table on Viral infections - Market size and forecast 2023-2028 ($ billion)
- Chart on Viral infections - Year-over-year growth 2023-2028 (%)
- Data Table on Viral infections - Year-over-year growth 2023-2028 (%)
6.4 Bacterial infections - Market size and forecast 2023-2028
- Chart on Bacterial infections - Market size and forecast 2023-2028 ($ billion)
- Data Table on Bacterial infections - Market size and forecast 2023-2028 ($ billion)
- Chart on Bacterial infections - Year-over-year growth 2023-2028 (%)
- Data Table on Bacterial infections - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
11.4 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
11.5 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
11.6 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
11.7 Dynavax Technologies Corp.
- Dynavax Technologies Corp. - Overview
- Dynavax Technologies Corp. - Product / Service
- Dynavax Technologies Corp. - Key offerings
11.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
11.9 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
11.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
11.11 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
11.12 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

性感染症 (STD) 治療の世界市場 (2024～2028年)

Global Sexually Transmitted Diseases (STD) Treatment Market 2024-2028

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：種類別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

性感染症 (STD) 治療の世界市場 (2024～2028年)

Global Sexually Transmitted Diseases (STD) Treatment Market 2024-2028

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模の評価

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 市場セグメンテーション：種類別

第7章 顧客情勢

第8章 地域別情勢

第9章 促進要因・課題・機会・抑制要因

第10章 競合情勢

第11章 競合分析

第12章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：種類別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録